Coherus Oncology, Inc. (CHRS)
1.07
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
1.075
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology Price : 1.07 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 1.06 | 1.12 | 1.05 | 1.07 | 1.697M |
| Oct 08, 2026 | 1.01 | 1.07 | 0.974 | 1.07 | 2.142M |
| Oct 07, 2026 | 1.02 | 1.08 | 1.01 | 1.01 | 1.234M |
| Oct 06, 2026 | 1.13 | 1.13 | 1.01 | 1.03 | 2.973M |
| Oct 05, 2026 | 1.16 | 1.16 | 1.08 | 1.12 | 2.009M |
| Oct 02, 2026 | 1.19 | 1.19 | 1.145 | 1.16 | 1.183M |
| Oct 01, 2026 | 1.20 | 1.21 | 1.145 | 1.16 | 709396.0 |
| Sep 30, 2026 | 1.18 | 1.23 | 1.155 | 1.21 | 1.580M |
| Sep 29, 2026 | 1.15 | 1.20 | 1.12 | 1.18 | 1.347M |
| Sep 28, 2026 | 1.13 | 1.15 | 1.10 | 1.14 | 1.143M |
| Sep 25, 2026 | 1.17 | 1.185 | 1.13 | 1.13 | 1.222M |
| Sep 24, 2026 | 1.25 | 1.265 | 1.17 | 1.17 | 1.569M |
| Sep 23, 2026 | 1.30 | 1.31 | 1.21 | 1.26 | 1.617M |
| Sep 22, 2026 | 1.39 | 1.39 | 1.22 | 1.30 | 4.537M |
| Sep 21, 2026 | 1.35 | 1.43 | 1.30 | 1.37 | 1.489M |
| Sep 18, 2026 | 1.23 | 1.35 | 1.225 | 1.35 | 3.125M |
| Sep 17, 2026 | 1.26 | 1.27 | 1.18 | 1.23 | 1.887M |
| Sep 16, 2026 | 1.34 | 1.35 | 1.21 | 1.22 | 1.291M |
| Sep 15, 2026 | 1.38 | 1.39 | 1.32 | 1.33 | 761961.0 |
| Sep 14, 2026 | 1.34 | 1.43 | 1.34 | 1.43 | 1.275M |
| Sep 11, 2026 | 1.378 | 1.38 | 1.325 | 1.33 | 529193.0 |
| Sep 10, 2026 | 1.33 | 1.36 | 1.30 | 1.34 | 1.020M |
| Sep 09, 2026 | 1.34 | 1.375 | 1.31 | 1.32 | 840616.0 |
| Sep 08, 2026 | 1.40 | 1.43 | 1.36 | 1.37 | 549199.0 |
| Sep 04, 2026 | 1.38 | 1.435 | 1.38 | 1.42 | 306060.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enanta Pharmaceuticals, Inc. | 12.50 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.68 |
| Anika Therapeutics, Inc. | 19.58 |
| Savara, Inc. | 4.92 |
Price Related Metrics
| PS Ratio | 2.772 |
| Price to Book Value | 2.717 |
| Earnings Yield | -95.44% |
| Market Cap | 165.28M |